• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec19
Sinopharm's Subsidiary Sinopharm Accord to Hold an Extraordinary General Meeting on December 31
22:41
Sinopharm Shareholders Approve New Board Appointments
09:00
Sinopharm Subsidiary Faced Consumer Complaint Over Food Safety Issues
08:12
Sinopharm's Subsidiary Listed as a Distributor for Non-Immunization Program Vaccines in Hubei Province
08:00
Dec18
Hong Kong Government Releases 'Blueprint for Chinese Medicine Development', Benefiting Related Industries
16:00
Heyuan Bio Announces Signing of Distribution Agreement with Sinopharm Group
13:18

Schedules & Filings

Schedules
Filings
Oct21
Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 158.99 B, Net Income 2.021 B, EPS 3.6093

Aug24
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 158.03 B, Net Income 2.19 B, EPS 0.6995

Aug22
Earning Release(CST)

FY2025 Semi-Annual Earning Release

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
02205
1.200
+73.91%
+0.510
02370
0.670
+57.65%
+0.245
00704
0.130
+52.94%
+0.045
01546
0.086
+45.76%
+0.027
02431
14.710
+31.22%
+3.500
08081
0.018
+28.57%
+0.004
09929
0.600
+20.00%
+0.100
01005
0.480
+20.00%
+0.080
08018
0.039
+18.18%
+0.006
08366
0.035
+16.67%
+0.005
View More